Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

The UK has not approved Algernon's Phase 1 DMT study

In this one instance I agree with tcm55. There is nothing in writing that suggests a DMT study has been given the go ahead to start in the UK. To my knowledge the application process is a 60 to 90 day window for approval. Algernon filed an application back in January 2022 (more than 150 days ago) and have not updated the public on it's status since. Instead, you are being dangled around the supposed start of DMT in Q3 2022. A timeline that's continued to get pushed back 1 2 3 quarters at a time. The stupidity never ends with how management communicates with shareholders. It's always some level of Smoke & Mirrors involved in everything coming out of the CEO's virtual office. Be it in writing or verbal. Any money raised by the clown team in the latest bomb fire sale of shares and warrants should go to getting results from a Phase 2 Chronic Cough clinical trial conducted in North America ASAP - results from start to finish within 12 months. We know it's possible because Bellus Health did it for it's shareholders. Aggressive timeline versus weak and fickle Christopher Moreau's decisions. Without it, you will continue suffering massive dilution and slow rolled data studies in other far away countries where he will attempt to lay the blame for a slow train to any data readouts. Moreau loves pointing the finger at everyone and everything else for his transparent ignorance at the helm of a publicly traded company. Christopher Moreau continues to make deals with the devil year after year with your money burning in his hands and burning a hole in your pocket.

Have @ it

M$